- Telehealth Visits
- Insurance plan information
Lawrence E. Kaplan, DO
Psychiatry • Psychosomatic Medicine- Telehealth Visits
- Insurance plan information
Lawrence E. Kaplan, DO
Psychiatry • Psychosomatic Medicine- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Psychosomatic Medicine, American Board of Psychiatry/Neurology-Psychiatry
- Psychiatry, American Board of Psychiatry/Neurology-Psychiatry
Fellowship
- Psychiatry, Brigham and Women's Hospital - MSO
Residency
- Psychiatry, Baylor COM Menninger Department of Psychiatry GME
Degree
- DO, Touro University College of Osteopathic Medicine
My expertise
Specialties
- Psychiatry
- Psychosomatic Medicine
- Psychiatric Oncology
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222510%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222510%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.